February 29, 2024

We are creating some awesome events for you. Kindly bear with us.

International MoU Between HK, Singapore and Europe Tech Talent

Image Credits: HKSTP, Press Release

Two biomedical companies under the Hong Kong Science and Technology Parks Corporation and a European leader in lung cancer research jointly announced that they will be entering into a Memorandum of Understanding (MoU), forging international collaborations between local talents and worldwide institutes via connection to corporates’ global network.

The partnership program includes two Science Park-based companies – the first being one of the research centres under the Health@InnoHK cluster funded by the Innovation and Technology Commission, and the other is a biotechnology company under the Hong Kong Science and Technology Parks Corporation.

The 5-year strategic partnership will study the preclinical efficacy of proprietary anticancer compounds developed by the Lead Principal Investigator and Managing Director of one of the research centres under the Health@InnoHK cluster funded using the second HKSTP company’s breakthrough technologies, including, Onco-PDO™ (Patient-Derived Organoids Chemotherapeutic Test), the biotechnology company’s Humanized Mice Technologies, & Next Generation Sequencing (NGS).

The research conducted will set forth the pathway in an attempt to make advanced cancer a treatable chronic disease and improve patients’ lives. Dr Rafael Rosell, a renowned lung cancer expert based in Spain, will serve as clinical and scientific advisor of the project, collaborating on the study of molecular mechanisms of the anticancer compounds and advising on future clinical trials.

Along with the multilateral research framework, the biotechnology company will contribute, to eligible cancer patients, their Onco-PDO™ Chemosensitivity Test, an in vitro drug screening on patient-specific organoid as a therapeutic tool in personalized treatment, leading to more durable responses with fewer side effects from less responsive treatment. The contribution covers cancer types including lung cancer, breast cancer, nasopharyngeal cancer, pancreatic cancer, and cervical cancer.

The Managing Director of the research centres stated that he hopes for the successful growth of the centre that will lay a foundation for the establishment of the National Innovation Centre in Hong Kong, which would become the engine to power “the development of Science and Technology for the benefit of mankind”.

Meanwhile, the European specialist stated that centralising cancer biology research is essential through international collaboration to develop new therapies and optimise treatments, such as those based on chemotherapy. Interdisciplinary, international collaboration could harmonise the understanding of oncogenesis, a determinant factor in augmenting curability and cancer elimination, he added.

The Regional Head of the biotechnology company stated that as an enterprise actively participating in this research project, the firm hopes to fill the gap to transform the wealth of expertise into actionable solutions meeting unsolved medical challenges and strengthen the interaction between the public and private sector, making research more sustainable.

The Commissioner for Innovation and Technology said that the signing of the MoU on the tripartite collaboration between one of the InnoHK research laboratories, the biotech firm and the European specialist signifies an important step in building a partnership between Hong Kong’s InnoHK research laboratories and renowned international collaborators in the field of health-care and life sciences.  She added that the government looks forward to the translation of the Laboratory’s R&D deliverables into new solutions and promising treatments in the foreseeable future.

The CEO of HKSTP stated that this high-level collaboration manifests the global potential of Hong Kong’s biomedical R&D ecosystem and realises InnoHK’s vision of building a world-class centre for translational research, while HKSTP will continue to support global talent and tech ventures on life-changing innovation missions to benefit society.


Qlik’s vision is a data-literate world, where everyone can use data and analytics to improve decision-making and solve their most challenging problems. A private company, Qlik offers real-time data integration and analytics solutions, powered by Qlik Cloud, to close the gaps between data, insights and action. By transforming data into Active Intelligence, businesses can drive better decisions, improve revenue and profitability, and optimize customer relationships. Qlik serves more than 38,000 active customers in over 100 countries.


CTC Global Singapore, a premier end-to-end IT solutions provider, is a fully owned subsidiary of ITOCHU Techno-Solutions Corporation (CTC) and ITOCHU Corporation.

Since 1972, CTC has established itself as one of the country’s top IT solutions providers. With 50 years of experience, headed by an experienced management team and staffed by over 200 qualified IT professionals, we support organizations with integrated IT solutions expertise in Autonomous IT, Cyber Security, Digital Transformation, Enterprise Cloud Infrastructure, Workplace Modernization and Professional Services.

Well-known for our strengths in system integration and consultation, CTC Global proves to be the preferred IT outsourcing destination for organizations all over Singapore today.


Planview has one mission: to build the future of connected work. Our solutions enable organizations to connect the business from ideas to impact, empowering companies to accelerate the achievement of what matters most. Planview’s full spectrum of Portfolio Management and Work Management solutions creates an organizational focus on the strategic outcomes that matter and empowers teams to deliver their best work, no matter how they work. The comprehensive Planview platform and enterprise success model enables customers to deliver innovative, competitive products, services, and customer experiences. Headquartered in Austin, Texas, with locations around the world, Planview has more than 1,300 employees supporting 4,500 customers and 2.6 million users worldwide. For more information, visit www.planview.com.


SIRIM is a premier industrial research and technology organisation in Malaysia, wholly-owned by the Minister​ of Finance Incorporated. With over forty years of experience and expertise, SIRIM is mandated as the machinery for research and technology development, and the national champion of quality. SIRIM has always played a major role in the development of the country’s private sector. By tapping into our expertise and knowledge base, we focus on developing new technologies and improvements in the manufacturing, technology and services sectors. We nurture Small Medium Enterprises (SME) growth with solutions for technology penetration and upgrading, making it an ideal technology partner for SMEs.


HashiCorp provides infrastructure automation software for multi-cloud environments, enabling enterprises to unlock a common cloud operating model to provision, secure, connect, and run any application on any infrastructure. HashiCorp tools allow organizations to deliver applications faster by helping enterprises transition from manual processes and ITIL practices to self-service automation and DevOps practices. 


IBM is a leading global hybrid cloud and AI, and business services provider. We help clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. Nearly 3,000 government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM’s hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently and securely. IBM’s breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and business services deliver open and flexible options to our clients. All of this is backed by IBM’s legendary commitment to trust, transparency, responsibility, inclusivity and service.

Send this to a friend